Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Bardin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bulletin De L'Academie Nationale De Medecine|June 2, 2006
[The benefits of computerized anticancer drug distribution]François Chast, Marie-Laure Brandely, Christophe Bardin
Journal of Clinical Pharmacy and Therapeutics|March 9, 2021
Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a reviewRobert Terkola, Christophe Bardin, Garbiñe Lizeaga Cundin, et al.
European Journal of Clinical Pharmacology|January 26, 2012
Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitusChristophe Bardin, Estelle Nobecourt, Etienne Larger, et al.
Critical Care (London, England)|January 17, 2007
Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationshipsBruno Mégarbane, Xavier Declèves, Vanessa Bloch, et al.
JCO Oncology Practice|June 17, 2020
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) GuidelinesBertrand Pourroy, Jean Francois Tournamille, Christophe Bardin, et al.
Therapeutic Advances in Medical Oncology|September 19, 2023
Ovarian cancer in the older patient: where are we now? What to do next?Frédérique Rousseau, Florence Ranchon, Christophe Bardin, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Molecular Pharmacology|May 15, 2021
Drug-Drug Interaction between Metformin and Sorafenib Alters Antitumor Effect in Hepatocellular Carcinoma CellsRania Harati, Marc Vandamme, Benoit Blanchet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bulletin De L'Academie Nationale De Medecine|June 2, 2006
[The benefits of computerized anticancer drug distribution]François Chast, Marie-Laure Brandely, Christophe Bardin
Journal of Clinical Pharmacy and Therapeutics|March 9, 2021
Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a reviewRobert Terkola, Christophe Bardin, Garbiñe Lizeaga Cundin, et al.
European Journal of Clinical Pharmacology|January 26, 2012
Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitusChristophe Bardin, Estelle Nobecourt, Etienne Larger, et al.
Critical Care (London, England)|January 17, 2007
Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationshipsBruno Mégarbane, Xavier Declèves, Vanessa Bloch, et al.
JCO Oncology Practice|June 17, 2020
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) GuidelinesBertrand Pourroy, Jean Francois Tournamille, Christophe Bardin, et al.
Therapeutic Advances in Medical Oncology|September 19, 2023
Ovarian cancer in the older patient: where are we now? What to do next?Frédérique Rousseau, Florence Ranchon, Christophe Bardin, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Molecular Pharmacology|May 15, 2021
Drug-Drug Interaction between Metformin and Sorafenib Alters Antitumor Effect in Hepatocellular Carcinoma CellsRania Harati, Marc Vandamme, Benoit Blanchet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
Pageof 3